Literature DB >> 8690168

Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.

J van den Born1, A A van Kraats, M A Bakker, K J Assmann, H B Dijkman, J A van der Laak, J H Berden.   

Abstract

Heparan sulphate-associated anionic sites in the glomerular basement membrane were studied in rats 8 months after induction of diabetes by streptozotocin and in age- adn sex-matched control rats, employing the cationic dye cuprolinic blue. Morphometric analysis at the ultrastructural level was performed using a computerized image processor. The heparan sulphate specificity of the cuprolinic blue staining was demonstrated by glycosaminoglycan-degrading enzymes, showing that pretreatment of the sections with heparitinase abolished all staining, whereas chondroitinase ABC had no effect. The majority of anionic sites (74% in diabetic and 81% in control rats) were found within the lamina rara externa of the glomerular basement membrane. A minority of anionic sites were scattered throughout the lamina densa and lamina rara interna, and were significantly smaller than those in the lamina rara externa of the glomerular basement membrane (p<0.001 and p<0.01 for diabetic and control rats, respectively). Diabetic rats progressively developed albuminuria reaching 40.3 (32.2-62.0) mg/24 h after 8 months in contrast to the control animals (0.8 (0.2-0.9) mg/24 h, p<0.002). At the same time, the number of heparan sulphate anionic sites and the total anionic site surface (number of anionic sites x mean anionic site surface) in the lamina rara externa of the glomerular basement membrane was reduced by 19% (p<0.021) and by 26% (p<0.02), respectively. Number and total anionic site surface in the remaining part of the glomerular basement membrane (lamina densa and lamina rara interna) were not significantly changed. We conclude that in streptozotocin-diabetic rats with an increased urinary albumin excretion, a reduced heparan sulphate charge barrier/density is found at the lamina rara externa of the glomerular basement membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8690168     DOI: 10.1007/bf00422365

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

Review 1.  Biosynthesis of heparin and heparan sulfate.

Authors:  U Lindahl; M Kusche; K Lidholt; L G Oscarsson
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

2.  Prevention of albuminuria by captopril in diabetic rats.

Authors:  A S Reddi
Journal:  Gen Pharmacol       Date:  1991

3.  Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane.

Authors:  S S Anderson; E C Tsilibary; A S Charonis
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

4.  Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.

Authors:  A S Reddi; R Ramamurthi; M Miller; S Dhuper; N Lasker
Journal:  Biochem Med Metab Biol       Date:  1991-02

5.  Reduced number of anionic sites is associated with glomerular basement membrane thickening in the diabetic BB-rat.

Authors:  S Chakrabarti; N Ma; A A Sima
Journal:  Diabetologia       Date:  1989-11       Impact factor: 10.122

6.  Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.

Authors:  J van den Born; A A van Kraats; M A Bakker; K J Assmann; L P van den Heuvel; J H Veerkamp; J H Berden
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

7.  Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria.

Authors:  H J Bangstad; A Kofoed-Enevoldsen; K Dahl-Jørgensen; K F Hanssen
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

8.  Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus.

Authors:  R L Vernier; M W Steffes; S Sisson-Ross; S M Mauer
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

9.  Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy.

Authors:  H Makino; S Ikeda; T Haramoto; Z Ota
Journal:  Nephron       Date:  1992       Impact factor: 2.847

10.  Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin.

Authors:  H Shimomura; R G Spiro
Journal:  Diabetes       Date:  1987-03       Impact factor: 9.461

View more
  9 in total

1.  Nef interaction with actin compromises human podocyte actin cytoskeletal integrity.

Authors:  Raymond Tan; Hitesh Patni; Pranai Tandon; Liming Luan; Bipin Sharma; Divya Salhan; Moin A Saleem; Peter W Mathieson; Ashwani Malhotra; Mohammad Husain; Poornima Upadhya; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2012-06-18       Impact factor: 3.362

Review 2.  The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.

Authors:  Kevin J McCarthy; Deborah J Wassenhove-McCarthy
Journal:  Microsc Microanal       Date:  2012-02       Impact factor: 4.127

Review 3.  The endothelium in diabetic nephropathy.

Authors:  Richard E Gilbert
Journal:  Curr Atheroscler Rep       Date:  2014-05       Impact factor: 5.113

4.  Structural alterations of the glomerular wall and vessels in early stages of diabetes mellitus: (light and transmission electron microscopic study).

Authors:  Allah R S Awad; M A Dkhil; M A Danfour
Journal:  Libyan J Med       Date:  2007-09-01       Impact factor: 1.657

5.  Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats.

Authors:  Célia M C Strunz; Monique Matsuda; Vera M C Salemi; Adriana Nogueira; Antonio P Mansur; Ismar N Cestari; Monica V Marquezini
Journal:  Cardiovasc Diabetol       Date:  2011-04-25       Impact factor: 9.951

6.  Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy.

Authors:  Mark B Zimering; Jane H Zhang; Peter D Guarino; Nicholas Emanuele; Peter A McCullough; Linda F Fried
Journal:  Front Endocrinol (Lausanne)       Date:  2014-08-11       Impact factor: 5.555

Review 7.  Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease.

Authors:  Laetitia Dou; Noémie Jourde-Chiche
Journal:  Toxins (Basel)       Date:  2019-10-05       Impact factor: 4.546

8.  Unchanged distribution density of anionic sites on the glomerular wall in rats with active heymann nephritis.

Authors:  Akihito Shimoi; Hirofumi Hatakeyama; Seiji Miyoshi; Mitsutoshi Watanabe
Journal:  J Toxicol Pathol       Date:  2013-04-22       Impact factor: 1.628

9.  Podocyte-specific deletion of NDST1, a key enzyme in the sulfation of heparan sulfate glycosaminoglycans, leads to abnormalities in podocyte organization in vivo.

Authors:  Terrel Sugar; Deborah J Wassenhove-McCarthy; Jeffrey D Esko; Toin H van Kuppevelt; Lawrence Holzman; Kevin J McCarthy
Journal:  Kidney Int       Date:  2013-08-07       Impact factor: 10.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.